While redox mechanism-based therapies are recognized for their significant impact on cancer treatment, Nrf-2 plays a crucial role in regulating cytoprotective functions by activating various genes associated with glutathione production and chemoresistance. The gene discussed is NFE2L2; the disease is cancer.